Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a case of multidrug-resistant Klebsiella pneumoniae and Acinectobacter baumannii, Gram-negative bacilli, which was only intermediate sensitive to colistin; a polymyxin E. Colistin has attracted more interest recently because of its significant activity against multi-resistant Pseudomonas aeruginosa, A. baumannii and K. pneumoniae, and the low resistance rates to it. The decrease in sensitivity of colistin against K. pneumoniae and A. baumanni sends alarming signals for the development of resistance to this antimicrobial drug. It is likely that colistin the important antimicrobial option against multi-resistant Gram-negative bacteria will be lost
Background: Multi drug resistant (MDR) bacteria are usually defined as when it is resistant to three...
Colistin is increasingly used as a last resort drug to treat infections with multidrug resistant Gra...
Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae carbapenemase (KPC) ha...
Colistin is an old drug, and its use has recently resurged because of increasing antibiotic resistan...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
Increasing number of infection cases caused by multiresistant Gram-negative bacteria or multidrug re...
Acinetobacter baumannii has emerged as a major cause of healthcare-associated infections. It commonl...
: Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectru...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii...
We report the emergence of colistin resistance in Klebsiella pneumoniae carbapenemase (KPC)-producin...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Background: Multi drug resistant (MDR) bacteria are usually defined as when it is resistant to three...
Colistin is increasingly used as a last resort drug to treat infections with multidrug resistant Gra...
Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae carbapenemase (KPC) ha...
Colistin is an old drug, and its use has recently resurged because of increasing antibiotic resistan...
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
Increasing number of infection cases caused by multiresistant Gram-negative bacteria or multidrug re...
Acinetobacter baumannii has emerged as a major cause of healthcare-associated infections. It commonl...
: Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectru...
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative bacteria...
Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity o...
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii...
We report the emergence of colistin resistance in Klebsiella pneumoniae carbapenemase (KPC)-producin...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Background: Multi drug resistant (MDR) bacteria are usually defined as when it is resistant to three...
Colistin is increasingly used as a last resort drug to treat infections with multidrug resistant Gra...
Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae carbapenemase (KPC) ha...